Rare diseases
Investigational molecules
Locations
24 Chemin de POUVOURVILLE, 31000 Toulouse, France
Hopital LARREY in Toulouse, France specialises in clinical trials of conditions such as Mast cell activation syndrome, Mastocytosis, Non-small cell lung cancer, and other specialisations. This site conducts important research.
The medical center is at the forefront of oncology research, particularly in the treatment of advanced non-small cell lung cancer (NSCLC). The institution is pioneering studies that explore the efficacy of combining PD-1 inhibitors with radiotherapy to enhance patient outcomes.
By integrating immunotherapy with traditional treatment modalities, the center aims to improve overall survival rates and set new standards in cancer care.
Specializing in mast cell activation syndrome (MCAS), the center is conducting advanced research to address severe cases unresponsive to conventional treatments. The focus is on evaluating the safety and efficacy of novel therapeutic agents like oral masitinib.
Through these studies, the center is committed to enhancing the quality of life for patients with complex immunological disorders.
Clinical trials currently enrolling participants at this site.
Study on Pembrolizumab and Chemotherapy with Radiation for Advanced Non-Small Cell Lung Cancer Patients
FranceStudy on the Effectiveness and Safety of Masitinib for Patients with Severe Systemic Mastocytosis Unresponsive to Treatment
FranceStudy on Masitinib for Patients with Severe Mast Cell Activation Syndrome Unresponsive to Treatment
FranceGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
